SCHEMBL29937697

SCHEMBL29937697

CSc1ncnn2c([C@H]3O[C@H](COCc4ccccc4)[C@@H](OCc4ccccc4)[C@@H]3OCc3ccccc3)ccc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.41
▸ PTPN1 P18031 9/20 0.38
▸ CDC25B P30305 8/20 0.38
▸ PDE2A O00408 1/20 0.38
▸ BCHE P06276 1/20 0.36
▸ PTPN2 P17706 5/20 0.36
▸ PTPN6 P29350 4/20 0.36
▸ PTPN11 Q06124 4/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ SSTR1 P30872 1/20 0.36
▸ SSTR2 P30874 1/20 0.36
▸ SSTR4 P31391 1/20 0.36
▸ SSTR3 P32745 1/20 0.36
▸ SSTR5 P35346 1/20 0.36
▸ TACR2 P21452 1/20 0.36
▸ NT5E P21589 1/20 0.35
▸ GJB2 P29033 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17106780 1.00 HTR1A (0.41) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL17106778 1.00 HTR1A (0.41) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL19343951 1.00 HTR1A (0.41) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL22002160 1.00 HTR1A (0.41) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL17106842 0.86 HTR1A (0.41) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL17106843 0.86 HTR1A (0.41) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL29937393 0.85 HTR1A (0.43) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL17106818 0.85 HTR1A (0.43) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL29937871 0.85 HTR1A (0.43) HTR1APTPN1CDC25BPDE2ABCHE
SCHEMBL25598746 0.85 HTR1A (0.43) HTR1APTPN1CDC25BPDE2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111233869-B Novel compound for preparing Rudexilvir key intermediate and preparation method thereof 杭州新博思生物医药有限公司 2022-09-16 — — CN disclosed
Send feedback